Last reviewed · How we verify
NCT06843356: RESCUE-BAO
Trial of Rescue Endovascular Treatment for Progressive Acute Mild Ischemic Stroke With Basilar Artery Occlusion With Extended Time Window
NA trial testing Endovascular Treatment in Acute Mild Ischemic Stroke in 159 participants. Currently enrolling.
30 September 2026
Quick facts
| Lead sponsor | First Affiliated Hospital of Wannan Medical College |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 159 |
| Start date | 1 June 2024 |
| Primary completion | 30 September 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Endovascular Treatment
Conditions studied
- Acute Mild Ischemic Stroke — all drugs for Acute Mild Ischemic Stroke →
- Basilar Artery Occlusion — all drugs for Basilar Artery Occlusion →
- Rescue Endovascular Treatment — all drugs for Rescue Endovascular Treatment →
- Extended Time Window — all drugs for Extended Time Window →
Sponsor
First Affiliated Hospital of Wannan Medical College
Who can join
18 and older, any sex, with Acute Mild Ischemic Stroke or Basilar Artery Occlusion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective, multicenter, open-label, blinded-endpoint, randomized controlled trial to evaluate whether best medical management (BMM) combined with endovascular therapy (EVT) improves neurological outcomes compared to BMM alone in patients with progressive acute mild ischemic stroke due to basilar artery occlusion within an extended time window.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06843356
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Endovascular Treatment
Trials testing the same drug.
- NCT07336927 — IAT-MeVO Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial · NA · not yet recruiting
- NCT07090941 — EVT in Acute Basilar Artery Occlusion With Large Infarction Core · NA · recruiting
- NCT06959199 — Endovascular Treatment Beyond 24 Hours for Acute Ischemic Stroke Caused by Anterior Circulation Large Vessel Stenosis · NA · recruiting
- NCT06740513 — The New Clinical Registration Trial of Interventional Treatment for Patients with Symptomatic Intracranial Artery Stenos · not yet recruiting
Other First Affiliated Hospital of Wannan Medical College trials
Trials by the same sponsor.
- NCT07501533 — Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke · Phase 2 · not yet recruiting
- NCT07127484 — Hemoadsorption for Severe Ischemic Stroke · NA · not yet recruiting
- NCT07232082 — Assessing Local Hypothermia and Endovascular Recanalization for Acute Stroke With a Large Core Infarction · NA · not yet recruiting
- NCT07027774 — Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter · Phase 4 · not yet recruiting
- NCT06990295 — Focused Ultrasound Spleen Stimulation and Inflammation in Septic Shock · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06843356 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Wannan Medical College
- Last refreshed: 15 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06843356.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing